VEGFA and Patent ductus arteriosus: Moreover, deletion of PKM2 impaired proliferation, increased apoptosis, and decreased PDA tumor growth by negatively impacting both HIF-1α and VEGF secretion through the NF-kB/p65, mTOR and Akt/c-Myc pathways [46,93,179,187].